Transcriptomics

Dataset Information

0

Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity


ABSTRACT: Chronic activation of inflammatory pathways and suppressed interferon are hallmarks of immunosuppressive tumors. Previous studies have shown that CD11b integrin agonists could enhance anti-tumor immunity through myeloid reprograming, but the underlying mechanisms remain unclear. Herein we find that CD11b agonists alter tumor-associated macrophage (TAM) phenotypes by repressing NF-κB signaling and activating interferon gene expression simultaneously. Repression of NF-κB signaling involves degradation of p65 protein and is context independent. In contrast, CD11b agonism induces STING/STAT1 pathway-mediated interferon gene expression through FAK-mediated mitochondrial dysfunction, with the magnitude of induction dependent on the tumor microenvironment and amplified by cytotoxic therapies. Using tissues from phase I clinical studies, we demonstrate that GB1275 treatment activates STING and STAT1 signaling in TAMs in human tumors. These findings suggest potential mechanism-based therapeutic strategies for CD11b agonists and identify patient populations more likely to benefit.

ORGANISM(S): Mus musculus

PROVIDER: GSE220959 | GEO | 2023/03/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA912163 | ENA
2019-06-10 | GSE128363 | GEO
2016-04-03 | GSE74078 | GEO
2013-10-10 | E-GEOD-51199 | biostudies-arrayexpress
2021-03-13 | GSE168784 | GEO
2024-01-22 | GSE253724 | GEO
2024-01-24 | GSE253681 | GEO
| PRJNA527269 | ENA
2015-10-14 | E-MTAB-3971 | biostudies-arrayexpress
2021-06-03 | GSE175984 | GEO